162 related articles for article (PubMed ID: 30258212)
1. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.
Goenka S; Sethi S; Pandey N; Joshi M; Jindal R
Spinal Cord; 2018 Dec; 56(12):1207-1211. PubMed ID: 30258212
[TBL] [Abstract][Full Text] [Related]
2. The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.
Oleson CV; Marino RJ; Formal CS; Modlesky CM; Leiby BE
Spinal Cord; 2020 Aug; 58(8):921-929. PubMed ID: 32055041
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability.
Crack LE; Haider IT; Simonian N; Barroso J; Gabel L; Schnitzer TJ; Edwards WB
Osteoporos Int; 2023 Sep; 34(9):1637-1645. PubMed ID: 37289320
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.
Bauman WA; Cirnigliaro CM; La Fountaine MF; Martinez L; Kirshblum SC; Spungen AM
J Bone Miner Metab; 2015 Jul; 33(4):410-21. PubMed ID: 25158630
[TBL] [Abstract][Full Text] [Related]
5. A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty.
Aro E; Moritz N; Mattila K; Aro HT
J Biomech; 2018 Jun; 75():35-45. PubMed ID: 29747966
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic Acid Attenuates Early Bone Loss at Forearm in Patients with Acute Spinal Cord Injury.
Goenka S; Sethi S
Indian J Orthop; 2020 Sep; 54(Suppl 1):127-133. PubMed ID: 32952920
[TBL] [Abstract][Full Text] [Related]
7. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
Bubbear JS; Gall A; Middleton FR; Ferguson-Pell M; Swaminathan R; Keen RW
Osteoporos Int; 2011 Jan; 22(1):271-9. PubMed ID: 20358358
[TBL] [Abstract][Full Text] [Related]
8. Progressive Sublesional Bone Loss Extends into the Second Decade After Spinal Cord Injury.
Cirnigliaro CM; Myslinski MJ; Asselin P; Hobson JC; Specht A; La Fountaine MF; Kirshblum SC; Forrest GF; Dyson-Hudson T; Spungen AM; Bauman WA
J Clin Densitom; 2019; 22(2):185-194. PubMed ID: 30503961
[TBL] [Abstract][Full Text] [Related]
9. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
[TBL] [Abstract][Full Text] [Related]
10. Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: a randomized, controlled trial.
Edwards WB; Haider IT; Simonian N; Barroso J; Schnitzer TJ
J Bone Miner Res; 2021 Nov; 36(11):2127-2138. PubMed ID: 34278611
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.
Zacharin M; Lim A; Gryllakis J; Siafarikas A; Jefferies C; Briody J; Heather N; Pitkin J; Emmanuel J; Lee KJ; Wang X; Simm PJ; Munns CF
J Clin Endocrinol Metab; 2021 Jul; 106(8):2328-2342. PubMed ID: 33954789
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results of a Randomized, Placebo-Controlled Pilot Trial.
Schnitzer TJ; Kim K; Marks J; Yeasted R; Simonian N; Chen D
PM R; 2016 Sep; 8(9):833-43. PubMed ID: 26828618
[TBL] [Abstract][Full Text] [Related]
13. Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial.
Cheung AS; Hoermann R; Ghasem-Zadeh A; Tinson AJ; Ly V; Milevski SV; Joon DL; Zajac JD; Seeman E; Grossmann M
J Bone Miner Res; 2020 Oct; 35(10):1871-1880. PubMed ID: 32542695
[TBL] [Abstract][Full Text] [Related]
14. Reduction in proximal femoral strength in patients with acute spinal cord injury.
Edwards WB; Schnitzer TJ; Troy KL
J Bone Miner Res; 2014 Sep; 29(9):2074-9. PubMed ID: 24677293
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia.
Gilfillan CP; Strauss BJ; Rodda CP; Bowden DK; Kean AM; Obaid M; Crawford BA
Calcif Tissue Int; 2006 Sep; 79(3):138-44. PubMed ID: 16969592
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
[TBL] [Abstract][Full Text] [Related]
17. Underestimation of bone loss of the spine with posterior-anterior dual-energy X-ray absorptiometry in patients with spinal cord injury.
Bauman WA; Kirshblum S; Cirnigliaro C; Forrest GF; Spungen AM
J Spinal Cord Med; 2010; 33(3):214-20. PubMed ID: 20737794
[TBL] [Abstract][Full Text] [Related]
18. Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial.
Edwards WB; Simonian N; Haider IT; Anschel AS; Chen D; Gordon KE; Gregory EK; Kim KH; Parachuri R; Troy KL; Schnitzer TJ
J Bone Miner Res; 2018 Oct; 33(10):1729-1740. PubMed ID: 29905973
[TBL] [Abstract][Full Text] [Related]
19. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
Chen F; Dai Z; Kang Y; Lv G; Keller ET; Jiang Y
Osteoporos Int; 2016 Apr; 27(4):1469-1476. PubMed ID: 26556733
[TBL] [Abstract][Full Text] [Related]
20. Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy.
Swenson KK; Nissen MJ; Anderson E; Shapiro A; Schousboe J; Leach J
J Support Oncol; 2009; 7(3):101-7. PubMed ID: 19507458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
